COVID-19 Treatment Cost · 2026 Pricing
COVID-19 Treatment Cost: Paxlovid Pricing, Online Doctor vs ER in 2026
A $79 video visit to assess Paxlovid eligibility. Free Paxlovid available for eligible uninsured and Medicare/Medicaid patients through December 2026 via PAXCESS. Must start within 5 days of symptoms.
Board-certified MD · 40+ states · evenings & weekends · HSA/FSA accepted · 4.97★ (212 reviews)
COVID-19 Visit at TeleDirectMD: $79
flat self-pay · insurance not required
- Same-day video visit with a board-certified MD
- Paxlovid eligibility assessment per CDC high-risk criteria
- E-prescription to your pharmacy, same-day if eligible
- 40+ states, evenings & weekends
- PAXCESS program navigation assistance
- HSA/FSA accepted
COVID-19 treatment cost in 2026 (uninsured or cash-pay):
Paxlovid (nirmatrelvir-ritonavir), the first-line COVID oral antiviral per CDC and IDSA guidelines, has a retail price of approximately $1,390–$1,447 per course without assistance (GoodRx, May 2026). Eligible uninsured and Medicare/Medicaid patients can get Paxlovid for free through December 31, 2026 via Pfizer's PAXCESS USG Patient Assistance Program (paxlovid.com). Commercially insured patients may pay as little as $0 with the PAXCESS co-pay card. A TeleDirectMD telehealth visit to assess eligibility and issue the prescription costs $79, vs. cash-pay urgent care at $150–$250 (BetterCare, 2026) or ER at $1,500–$3,000 (BetterCare, 2026).
Cost Plus Drugs: Paxlovid. not carried — brand-only antiviral.
COVID-19 antiviral treatment has a confusing pricing landscape in 2026: Paxlovid's retail price exceeds $1,400, yet eligible patients can get it free. The key is knowing your eligibility, high-risk criteria, insurance status, and the PAXCESS patient assistance program, and acting fast, since Paxlovid must start within 5 days of symptom onset. A telehealth visit is a quick, lower-cost way to be assessed and get a prescription routed to your pharmacy. We pulled 2026 pricing from GoodRx, PAXCESS program terms, BetterCare, and Mira Health so you know exactly what to expect.
The numbers
COVID-19 Treatment Cost by Care Setting (2026, Cash-Pay)
Visit cost + Paxlovid where applicable. Paxlovid cost varies dramatically by insurance and PAXCESS eligibility, see notes. Symptomatic-management-only costs (OTC) listed separately.
| Setting | Cost | What's included |
|---|---|---|
| TeleDirectMD (online) | $79 visit; Paxlovid $0–$1,447 depending on eligibility | $79 visit + Paxlovid free via PAXCESS (eligible pts) or $1,390–$1,447 retailTeleDirectMD; GoodRx; PAXCESS |
| Telehealth (national average) | $40–$100 visit; Paxlovid same as above | Visit varies by platform; Paxlovid cost independent of visit channelGoodRx; BetterCare 2025 |
| Primary care (cash-pay) | $110–$265 visit; Paxlovid separate | In-person evaluation; Paxlovid Rx same cost as aboveMira Health, 2025 |
| Urgent care (in-person) | $150–$250 visit; Paxlovid separate | Walk-in COVID evaluation; rapid test often bundledBetterCare, 2026 |
| Emergency room (uninsured) | $1,500–$3,000 | ED visit + testing; appropriate only for severe COVID (hypoxia, respiratory distress)BetterCare, 2026 |
Why the difference
Paxlovid Pricing, PAXCESS Access, and When COVID Needs In-Person Care
Paxlovid (nirmatrelvir-ritonavir) transitioned from a U.S. government-distributed free drug to the commercial market in late 2023. The retail list price is now approximately $1,390–$1,447 per 5-day course, unaffordable for most uninsured patients paying out of pocket (GoodRx, May 2026). However, Pfizer's PAXCESS patient assistance program significantly changes the calculus: eligible patients on Medicare, Medicaid, TRICARE, or who are uninsured can receive Paxlovid for free through December 31, 2026 via the U.S. Government Patient Assistance Program (USG PAP), operated by Pfizer (paxlovid.com; call 1-877-219-7225). Commercially insured patients can use the PAXCESS co-pay savings card to pay as little as $0, up to the program's annual maximum (see program terms). The CDC and IDSA both strongly recommend Paxlovid as the first-line oral antiviral for mild-to-moderate COVID in adults at higher risk for severe disease, defined as adults 50+, unvaccinated or not up-to-date, or with chronic conditions including diabetes, obesity, chronic lung disease, heart disease, or immunocompromise.
Per CDC COVID treatment guidance (February 2026), Paxlovid must be started within 5 days of symptom onset, the 5-day window is hard. This timing makes telehealth the most efficient access point: a $79 TeleDirectMD visit gets you assessed and a prescription routed to your pharmacy within hours of booking. A 2026 JAMA Network Open study by Penn Medicine found telemedicine episodes averaged $96 vs. $509 for in-person care (Penn Medicine, 2026). For COVID specifically, where the clinical decision (eligible or not?) rarely needs a physical exam and a home test result is usually available, telehealth works well. Paxlovid carries important drug-drug interactions with ritonavir, a telehealth physician will screen your medication list.
For patients who do not meet Paxlovid eligibility criteria (low risk, healthy, young, vaccinated with mild symptoms), treatment is supportive: rest, hydration, and OTC symptom management. According to IDSA COVID treatment guidelines (2025), patients without risk factors for progression to severe disease (estimated hospitalization risk ≤0.5%) are unlikely to benefit from antiviral treatment. OTC symptom management, acetaminophen or ibuprofen for fever/pain, nasal saline, fluids, costs under $15 at any pharmacy. The ER is reserved for severe COVID: oxygen saturation below 94%, shortness of breath at rest, chest pain, or confusion.
Who benefits
Who Benefits Most From a Telehealth COVID Visit
High-risk adults needing Paxlovid fast
Age 50+, diabetic, immunocompromised, or with chronic lung/heart disease, you're in the 5-day window. A $79 telehealth visit gets you assessed and a prescription at your pharmacy today.
Uninsured or Medicare patients navigating PAXCESS
Paxlovid's retail price is $1,390+. If you're uninsured or on Medicare and eligible, the PAXCESS USG PAP can provide it free through December 2026. A telehealth visit helps you navigate eligibility.
Commercially insured patients with high deductibles
The PAXCESS co-pay card can lower your cost to as little as $0 if your plan covers Paxlovid. A $79 telehealth visit costs less than a $150–$250 cash-pay urgent care visit, though your plan's urgent care copay may be lower.
Lower-risk patients unsure if they need Paxlovid
Healthy, vaccinated, and mildly symptomatic? A $79 telehealth assessment clarifies whether you're in a high-risk category, and saves you an unnecessary urgent care trip.
Is it right for you?
When COVID Belongs in Telehealth vs. In-Person
Good fit for a video visit
- Confirmed or suspected mild-to-moderate COVID in adults with ≥1 high-risk criterion (age 50+, diabetes, chronic lung disease, heart disease, obesity, immunocompromise)
- Paxlovid eligibility assessment, within 5 days of symptom onset
- Drug interaction screening before starting Paxlovid (ritonavir has many interactions)
- Low-risk adults needing guidance on OTC symptomatic management only
- Patients with mild COVID and questions about isolation, return-to-work, or rebound symptoms
- Follow-up for patients who completed Paxlovid and are experiencing "rebound" COVID symptoms
Better seen in person
- Oxygen saturation below 94% on room air, call 911 or go to the ER
- Shortness of breath at rest, chest pain, or persistent pressure in the chest
- Confusion, altered mental status, or inability to stay awake
- Persistent vomiting preventing oral medication
- Severe liver disease (Child-Pugh C), where Paxlovid is not recommended
- Anyone under 18 (TeleDirectMD treats adults only)
Decision guide
COVID-19: Telehealth, Urgent Care, or ER?
Shortness of breath at rest, SpO2 <94%, chest pain, or confusion?
Call 911 or go to the ER now. These are signs of severe COVID requiring hospital-level care. An uninsured ER visit typically costs $1,500–$3,000 (BetterCare, 2026), and it is the right place for a medical emergency.
Mild-to-moderate symptoms + high-risk criterion + within 5 days of onset?
Book a $79 telehealth visit immediately. Paxlovid eligibility can be assessed and a prescription issued within hours. Free Paxlovid available for eligible uninsured/Medicare patients via PAXCESS.
Low-risk, vaccinated, healthy adult with mild symptoms?
Supportive care only, rest, fluids, acetaminophen or ibuprofen. IDSA guidelines suggest antiviral treatment unlikely to benefit patients with ≤0.5% hospitalization risk. OTC management costs under $15.
High-risk but uncertain about Paxlovid drug interactions with your medications?
Book a telehealth visit. Ritonavir (the booster in Paxlovid) has significant drug-drug interactions with statins, blood thinners, and other common meds. A physician screens your full list before prescribing.
Medication pricing
COVID-19 Treatment Medication Costs (2026)
Paxlovid cost varies by insurance status and PAXCESS program eligibility. OTC symptomatic management costs are independent of insurance.
| Medication | Cost |
|---|---|
| Paxlovid (nirmatrelvir-ritonavir), first-line oral antiviral, high-risk pts | $1,390–$1,447 retail; $0 via PAXCESS (Medicare/Medicaid/uninsured through Dec 2026); $0 commercially insured with co-pay cardsource |
| Paxlovid PAXCESS USG Patient Assistance Program, free for eligible pts | $0 (Medicare, Medicaid, uninsured through Dec 31, 2026)source |
| Acetaminophen 500mg (Tylenol generic), OTC fever/pain | $5–$10 OTC (no Rx needed)source |
| Ibuprofen 200mg (Advil generic), OTC fever/pain/inflammation | $5–$10 OTC (no Rx needed)source |
Common questions
Frequently asked questions
How much does Paxlovid cost without insurance in 2026?
Without insurance and without assistance programs, Paxlovid's retail price is approximately $1,390–$1,447 per 5-day course (GoodRx, May 2026). However, eligible uninsured patients can receive Paxlovid for free through December 31, 2026 via Pfizer's PAXCESS U.S. Government Patient Assistance Program, enroll at paxlovid.com or call 1-877-219-7225.
Is Paxlovid free with Medicare in 2026?
Eligible Medicare patients can receive Paxlovid at no cost through the PAXCESS USG Patient Assistance Program, extended through December 31, 2026 (Pfizer/paxlovid.com). Medicare Part D also caps annual out-of-pocket drug costs ($2,000 in 2025 and $2,100 in 2026). Patients with Medicare who face high co-pays and meet income thresholds may qualify for the program, enrollment is required.
What does the PAXCESS co-pay card do for commercially insured patients?
Commercially insured patients who present the PAXCESS co-pay savings card at the pharmacy may pay as little as $0 for Paxlovid, up to the program's annual maximum (see program terms). The card is available at paxlovid.com. This applies only to patients with commercial (private) insurance, not Medicare or Medicaid.
How much does a telehealth COVID visit cost vs. urgent care vs. ER?
A TeleDirectMD telehealth visit costs $79. Cash-pay urgent care runs $150–$250 (BetterCare, 2026). An uninsured ER visit typically costs $1,500–$3,000, appropriate only for severe disease (hypoxia, chest pain, confusion). For eligible high-risk patients paying cash, a $79 telehealth visit plus free Paxlovid through PAXCESS keeps out-of-pocket cost low; insured patients may pay a lower copay through their plan.
Who is eligible for Paxlovid?
Adults (or children ≥12 years, ≥40 kg) with mild-to-moderate COVID who have at least one risk factor for severe disease: age 50+, unvaccinated, diabetes, overweight or obesity (BMI ≥25), chronic lung disease, heart disease, chronic kidney disease, immunocompromise, or other CDC-listed conditions. Treatment must start within 5 days of symptom onset. CDC eligibility details at cdc.gov/covid/risk-factors.
What are the most important Paxlovid drug interactions?
Ritonavir, the pharmacokinetic booster in Paxlovid, is a potent CYP3A inhibitor with significant interactions including statins (simvastatin, lovastatin, hold during treatment), certain blood thinners (warfarin, INR monitoring needed), immunosuppressants, antiarrhythmics, and others. A telehealth physician will screen your medication list before prescribing. Never start Paxlovid without this review.
Does COVID-19 treatment from a telehealth visit cost the same as in-person?
The drug cost (Paxlovid) is the same regardless of where the prescription comes from. The visit cost differs: $79 telehealth vs. $150–$250 cash-pay urgent care (BetterCare, 2026). Penn Medicine's 2026 JAMA Network Open study found care episodes that began with telemedicine averaged $96 in charges vs. $509 for those that began in person. For COVID confirmed by a home test, telehealth can provide the same evaluation at lower cost.
What if I have COVID but don't meet Paxlovid eligibility criteria?
For low-risk, healthy, vaccinated adults with mild COVID, IDSA guidelines suggest antiviral treatment is unlikely to provide meaningful benefit (hospitalization risk ≤0.5%). Supportive management, rest, hydration, OTC acetaminophen or ibuprofen for fever, costs under $15 at any pharmacy. A $79 telehealth visit confirms your risk classification and provides clear guidance on when to escalate to in-person care.
Explore more
Related pricing & comparisons
Clinical & pricing sources
References
- CDC, COVID-19 Treatment Types (February 2026)
- CDC, COVID-19 High-Risk Conditions
- CDC, COVID-19 Outpatient Treatment Clinical Care (2026)
- IDSA, Antiviral Treatment for Mild-to-Moderate COVID-19 Guideline (2025)
- Paxlovid.com, PAXCESS Co-Pay Savings & USG Patient Assistance Program
- GoodRx, Paxlovid pricing (May 2026)
- GoodRx, Paxlovid: how much without insurance
- BetterCare, Urgent care cost without insurance (2026)
- BetterCare, ER visit cost (2026)
- Mira Health, Primary care cost without insurance (2025)
- Penn Medicine, Telemedicine vs. in-person costs, JAMA Network Open (2026)
See a board-certified MD today
A flat $79 video visit. No insurance required, prescription sent to your pharmacy same-day.
Book a Visit, $79 →Prescribing limits: before you book
Can TeleDirectMD prescribe IV medications or IM shots?
TeleDirectMD does not prescribe intravenous (IV) medications or intramuscular (IM) medications, except EpiPen (epinephrine auto-injector) refills when clinically appropriate. This includes IV fluids and infusions, and IM antibiotic or steroid shots. We cannot issue these prescriptions for administration at another clinic or by another provider.
How long can a TeleDirectMD prescription last, including refills?
Every TeleDirectMD prescription, including all refills, covers no more than a 90-day supply. To continue a medication beyond 90 days, you need a new visit. There are no exceptions.

